Dr. Peter Black, MD
Claim this profileVancouver Prostate Centre
Area of expertise
Bladder Cancer
Peter Black, MD has run 6 trials for Bladder Cancer. Some of their research focus areas include:
Transitional Cell Carcinoma
Peter Black, MD has run 5 trials for Transitional Cell Carcinoma. Some of their research focus areas include:
Affiliated Hospitals
Vancouver Prostate Centre
The Prostate Centre- Diamond Health Care Centre
Clinical Trials Peter Black, MD is currently running
PDT
for Bladder Cancer
This trial tests a new treatment for bladder cancer patients who do not respond to or cannot tolerate standard therapy. The treatment uses a drug called Ruvidar® that is activated by a special light to kill cancer cells in the bladder.
Recruiting
1 award
Phase 2
10 criteria
ST-02
for Urothelial Carcinoma
The goal of this prospective clinical trial is to investigate the safety and efficacy of ST-02 (mucoadhesive gemcitabine suspension for pyelocaliceal instillation) to treat Upper Tract Urothelial Carcinoma (UTUC) in participants who have a low-grade tumor. The main questions this study aims to answer are: 1. Can ST-02 effectively eradicate UTUC by 3 months? 2. Is ST-02 safe for patients with UTUC? Participants in this study will receive ST-02, a new formulation with gemcitabine once weekly for six weeks. Gemcitabine is known to be an effective drug in treating urothelial carcinoma. This new formulation will be instilled directly into the upper urinary tract (renal pelvis) and will allow the chemotherapeutic to work locally for an extended period of time. The administration process will be retrograde (via a small catheter inserted up into the kidney, under anesthesia) or antegrade (via a nephrostomy, in the clinic) once weekly for six weeks. Safety and efficacy will be monitored for up to a year after the initial response assessment.
Recruiting
1 award
Phase 2 & 3
More about Peter Black, MD
Clinical Trial Related
6 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Peter Black, MD has experience with
- ST-02
- Cxbladder
- Urothelial Cancer Screening Using Urine Tumor DNA Test
- Urothelial Cancer Screening Using Urine Cytology
- OGX-427
- MRI
Breakdown of trials Peter Black, MD has run
Bladder Cancer
Transitional Cell Carcinoma
Urothelial Carcinoma
Kidney Cancer
Hematuria
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Peter Black, MD specialize in?
Peter Black, MD focuses on Bladder Cancer and Transitional Cell Carcinoma. In particular, much of their work with Bladder Cancer has involved Stage I patients, or patients who are Stage II.
Is Peter Black, MD currently recruiting for clinical trials?
Yes, Peter Black, MD is currently recruiting for 4 clinical trials in Vancouver British Columbia. If you're interested in participating, you should apply.
Are there any treatments that Peter Black, MD has studied deeply?
Yes, Peter Black, MD has studied treatments such as ST-02, Cxbladder, Urothelial cancer screening using urine tumor DNA test.
What is the best way to schedule an appointment with Peter Black, MD?
Apply for one of the trials that Peter Black, MD is conducting.
What is the office address of Peter Black, MD?
The office of Peter Black, MD is located at: Vancouver Prostate Centre, Vancouver, British Columbia V5Z1M9 Canada. This is the address for their practice at the Vancouver Prostate Centre.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.